Cornerstone support for Kingstone as NT Pharma preps IPO
Property developers will provide much of the cornerstone investment for the Hong Kong IPO of China Kingstone Marble, which is due to start bookbuilding next week. Cornerstone investment will account for around 25% of the deal, which is expected to raise about $280m-equivalent, according to a banker close to the deal. Citi is sole bookrunner.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts